Isaacs, JD; Boenink, M
(2020)
Biomarkers for dementia: too soon for routine clinical use.
Lancet Neurol, 19 (11).
pp. 884-885.
ISSN 1474-4465
https://doi.org/10.1016/S1474-4422(20)30365-3
SGUL Authors: Isaacs, Jeremy
Microsoft Word (.docx)
Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (25kB) |
Official URL: https://doi.org/10.1016/S1474-4422(20)30365-3
Item Type: | Article | ||||||||
---|---|---|---|---|---|---|---|---|---|
Additional Information: | © 2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/ | ||||||||
Keywords: | Alzheimer Disease, Amyloidosis, Biomarkers, Dementia, Fluorodeoxyglucose F18, Humans, Humans, Dementia, Alzheimer Disease, Amyloidosis, Fluorodeoxyglucose F18, Biomarkers, 1103 Clinical Sciences, 1109 Neurosciences, Neurology & Neurosurgery | ||||||||
SGUL Research Institute / Research Centre: | Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) | ||||||||
Journal or Publication Title: | Lancet Neurol | ||||||||
ISSN: | 1474-4465 | ||||||||
Language: | eng | ||||||||
Dates: |
|
||||||||
PubMed ID: | 33098787 | ||||||||
Web of Science ID: | WOS:000581121200007 | ||||||||
Go to PubMed abstract | |||||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/116099 | ||||||||
Publisher's version: | https://doi.org/10.1016/S1474-4422(20)30365-3 |
Statistics
Item downloaded times since 15 Feb 2024.
Actions (login required)
Edit Item |